Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Recovering-purified-antibodies-from-egg-yolk

 Peptide fragments of myelin basic protein
OF THE INVENTION All patent applications, patents and publications cited in this specification are ...


 Targeted therapeutic delivery of vitamin D compounds
The present invention provides conjugates of vitamin D compounds or analogs and a targeting ...


 Production and use of monoclonal antibodies to phosphotyrosine-containing proteins
OF THE PREFERRED EMBODIMENTS A hybridoma secreting monoclonal antibodies that bind to PT-residues ...


 Trichothecene antibody conjugates
I claim: 1. A conjugate of a trichothecene and an antibody or antibody fragment, said antibody or ...


 Monoclonal antibody to human protein C
What is claimed is: 1. A monoclonal antibody which is specific to human protein C which has calcium ...


 Method for providing a cell culture from a transgenic non-human mammal
We claim: 1. A method of providing a cell culture comprising (1) providing a transgenic non-human ...


 Method of gene transfer into chickens and other avian species
A method is described for introducing foreign genes or foreign nucleic acid sequences into somatic ...


 DNA vector with isolated CDNA gene encoding metallopanstimulin
The present invention is based upon the discovery of a new and heretofore unrecognized type of ...


 Method for preparing immunoglobulin fragments
Pursuant to the present invention, there is provided an improved method for specific fragmentation ...


 Morpholino-subunit combinatorial library and method
The invention includes, in one aspect, a combinatorial library of non-biological oligomers formed ...


 Recovering purified antibodies from egg yolk

Details
Inventors: Polson, Alfred;
Assignee: The South African Inventions Development Corporation (Pretoris, ZA)
Primary Examiner: Fagelson; Anna P.
Assistant Examiner:
Attorney, Agent or Firm: Millen & White

Immunological preparations are prepared by immunizing hens with an antigen, preferably to a stage of hyperimmunization. The eggs of the immunized hens are collected, the yolk is separated from the eggs, followed by separation of the lipid content of the yolk. The antibodies in the egg yolk are then rendered indispersable with the aid of a water-soluble linear filamentary non-charged polymer precipitant such as PEG and the indispersable antibodies are recovered. This precipitation of antibodies is preferably preceded by a precipitation of caseinaceous proteins at lower polymer concentrations. The immunological preparations are useful for diagnostic purposes and in appropriate cases also for the treatment of pathological conditions.

DETAILED DESCRIPTION What is claimed is: 1.
A process for recovering purified IgY antibodies from fowl egg yolk containing said antibodies, comprising the steps of (a) rendering the lipid content and the caseinous protein of the egg yolk water-indispersable by mixing the yolk with water and a water-soluble linear filamentary non-charged polymer precipitant in a concentration sufficient to substantially suppress the dispersability of lipids and caseinous protein without substantially suppressing the dispersability of IgY antibodies; (b) separating egg yolk substances thus rendered indispersable, including the lipid content, from an aqueous phase which still contains the antibodies dispersed therein; and (c) recovering the antibodies from said aqueous phase.
2.
A process according to claim 1, wherein the precipitant is selected from the group consisting of polyethylene glycols, polypropylene glycols, mixed polymers of ethylene glycols and higher homologues thereof and poly-1,4-dihydroxy butaneglycol.
3.
A process according to claim 1, wherein step (b) comprises separating the precipitated caseinous protein and then filtering the resultant supernatant, on the surface of which floats the lipid layer, through an absorbent filter plug adapted to retain the lipid layer.
4.
A process according to claim 1, wherein the precipitant is selected from the group consisting of polyalkylene glycols and dextran.
5.
A process according to claim 4, wherein the molecular weight of the precipitant is within the range 2000 to 30,000.
6.
A process according to claim 1, wherein the concentration of precipitant in step (a) corresponds to a concentration of more than 3% and less than 4% by weight of polyethylene glycol 6000 based on the volume of aqueous yolk.
7.
A process according to claim 6, wherein the yolk is diluted with between 1 and 10 parts by volume of water.
8.
A process according to claim 7, wherein the water is buffered to a pH of between 6 and 8.
9.
A process according to claim 1, wherein step (c) comprises increasing the concentration of the water-soluble linear filamentary non-charged polymer precipitant to a concentration sufficient to selectively substantially suppress the dispersability of the antibodies, and separating purified substantially homogeneous antibodies thus rendered indispersable from an aqueous phase containing the precipitant



Related patents
  Analogs of viscosin and their uses
OF THE INVENTION Viscosin is a peptide lactone composed of alternating D and L amino acids with a .beta.-D-hydroxydecanoyl dipeptide side chain. This peptide has ...
  Single polypeptide chain binding molecules
The present invention starts with a computer based system and method to determine chemical structures for converting two naturally aggregated but chemically separated ...
  Bcl-2 and R-ras complex
Generally, the nomenclature used hereafter and the laboratory procedures in cell culture, molecular genetics, and nucleic acid chemistry and hybridization described ...
  Heterodimeric receptor libraries using phagemids
A new surface-integration technology has been discovered for expressing a heterodimeric recombinant gene product on the surface of a filamentous phage containing the ...
  Method for producing highly reactive polyisobutenes
We claim: 1. A process for the preparation of highly reactive polyisobutenes, in which a) isobutene is polymerized in the presence of a complex of boron trifluoride and ...
  Device and mixture for testing for immune responses to food
In accordance with the present invention the aforementioned needs are fulfilled by providing an inexpensive, simple and quick test for detecting an individual's Type I, I...
  Compounds for immunotherapy of prostate cancer and methods for their use
OF THE INVENTION As noted above, the present invention is generally directed to compositions and methods for the immunotherapy of prostate cancer. The inventive ...
  Compositions and methods for the therapy and diagnosis of prostate cancer
Briefly stated, the present invention provides compositions and methods for the diagnosis and therapy of cancer, such as prostate cancer. In one aspect, the present ...
  Superantigen based methods and compositions for treatment of diseases
What is claimed is: 1. A pharmaceutical compound comprising a therapeutic antigen and superantigen, wherein said super antigen is conjugated to the therapeutic antigen ...
  Tetra and penta-peptides useful in regulating the immune system
The present invention describes a series of thysplenin peptide analogs capable of regulating the function of cells of the immune system. As one aspect, the present ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved